National Pharmaceutical Pricing Authority fixes the retail price for certain formulations; overcharged amount (with interest) to be imposed for non-compliance

National Pharmaceutical Pricing Authority fixes the retail price for certain formulations; overcharged amount (with interest) to be imposed for non-compliance

National Pharmaceutical Pricing Authority fixes the retail price for certain formulations; overcharged amount (with interest) to be imposed for non-compliance

by Lexplosion Solution | Apr 21, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Central Government issues Guidelines for Scheme to Strengthen Pharmaceuticals Industry (SPI); aims to strengthen existing infrastructure facilities to improve productivity, quality and sustainability

Central Government issues Guidelines for Scheme to Strengthen Pharmaceuticals Industry (SPI); aims to strengthen existing infrastructure facilities to improve productivity, quality and sustainability

by Lexplosion Solution | Apr 12, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Central Govt. extends timeline for submission of applications under the ‘PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials / Drug Intermediates and APIs’ till 31st March, 2022

Central Govt. extends timeline for submission of applications under the ‘PLI Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials / Drug Intermediates and APIs’ till 31st March, 2022

by Lexplosion | Mar 25, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Public comments invited on the draft amendments to the New Drugs and Clinical Trials Rules by 5th Feb, 2022; proposes to introduce deemed approval w.r.t. registration of Ethics Committee, conducting all clinical trials etc.

Public comments invited on the draft amendments to the New Drugs and Clinical Trials Rules by 5th Feb, 2022; proposes to introduce deemed approval w.r.t. registration of Ethics Committee, conducting all clinical trials etc.

by Lexplosion | Feb 1, 2022 | Central, Drug, OPS

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017

DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017

by Lexplosion Solution | Aug 27, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

« Older Entries

Next Entries »